Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2022-03-04 2022-02-22
Drug Identification Number 02460602 02460602
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION HYDROMORPHONE HYDROCHLORIDE INJECTION
Common or Proper name HYDROMORPHONE HYDROCHLORIDE INJECTION HYDROMORPHONE HYDROCHLORIDE INJECTION
Company Name STERIMAX INC STERIMAX INC
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 AMPOULES 10 AMPOULES
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-02-25 2022-02-25
Actual start date
Estimated end date 2022-03-15 2022-03-15
Actual end date 2022-03-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Limited inventory remaining at the Distributors. Limited inventory remaining at the Distributors.
Health Canada comments